Xetra
22.04.26 | 17:35
46,895 Euro
+1,41 % +0,650
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 47,285 | 47,375 | 22.04. | |
| 47,265 | 47,740 | 22.04. |
► 22.04.: | | | | | | | | |
► 21.04.: | | | | | | | | | 17:30
► Aktueller MODERNA Börsenkurs + Xetra-Orderbuch
► 21.04.: | | | | | | | | | 17:30
► Aktueller MODERNA Börsenkurs + Xetra-Orderbuch
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 51,76 | 50 | |||
| 48,000 | 60 | |||
| 47,160 | 200 | |||
| 47,105 | 20 | |||
| 47,095 | 20 | |||
| 47,085 | 50 | |||
| 46,950 | 182 | |||
| 46,930 | 182 | |||
| 46,920 | 182 | |||
| 46,905 | 354 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/0qf.htm [/URL] | ||||
| 172 | 46,740 | |||
| 182 | 46,735 | |||
| 50 | 46,560 | |||
| 20 | 46,550 | |||
| 20 | 46,540 | |||
| 182 | 45,450 | |||
| 100 | 41,000 | |||
| 37 | 36,000 | |||
| 55 | 26,000 | |||
| 120 | 20,800 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 938 | 1,386 | 1.300 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:30:01 | 47,100 | 62 |
| 17:28:57 | 47,015 | 1 |
| 17:26:02 | 46,945 | 75 |
| 17:20:07 | 46,860 | 149 |
| 17:15:47 | 46,865 | 105 |
| 17:15:36 | 46,840 | 23 |
| 17:15:36 | 46,840 | 52 |
| 17:15:36 | 46,825 | 45 |
| 17:09:22 | 46,920 | 21 |
| 17:09:22 | 46,920 | 28 |
| 17:09:22 | 46,920 | 2 |
| 17:09:22 | 46,920 | 75 |
| 16:58:52 | 47,050 | 90 |
| 16:58:48 | 47,060 | 87 |
| 16:58:48 | 47,055 | 58 |
| 16:58:37 | 46,945 | 1 |
| 16:53:37 | 46,765 | 59 |
| 16:47:45 | 46,880 | 55 |
| 16:47:45 | 46,885 | 150 |
| 16:30:26 | 47,355 | 124 |
| Tagesumsatz Xetra | +0,650 +1,41 % | 5.689 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial | 7 | BioPharma Dive | ||
| Mi | Moderna starts late-stage trial for bird flu vaccine | 8 | Seeking Alpha | ||
| Mi | Pivotal trial of Moderna's H5N1 bird flu jab gets underway | 4 | pharmaphorum | ||
| Mi | Moderna begins phase 3 trial of H5 bird flu vaccine candidate | 9 | Investing.com | ||
| MODERNA Aktie jetzt für 0€ handeln | |||||
| Mi | Moderna, Inc.: Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate | 524 | ACCESS Newswire | Phase 3 study is supported by the Coalition for Epidemic Preparedness Innovations to help strengthen global preparedness against a significant pandemic threat CAMBRIDGE, MA / ACCESS Newswire / April... ► Artikel lesen |
1 2 3 4 5 Weiter >>
452 Nachrichten in den letzten 12 Monaten
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Mi | Morning Market Movers: Axe Compute, Inhibrx Biosciences, Huachen AI Parking Management Technology, 1-800-FLOWERS.COM See Big Swings | AFX News | OTTAWA (dpa-AFX) - At 9:00 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| Mi | GenScript Biotech Corporation: GenScript Leaders Named Entrepreneur Of The Year 2026 New Jersey Finalists | PR Newswire | PISCATAWAY, N.J., April 22, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced that CEO Sherry Shao and Co-Founder Dr. Frank Zhang have been selected as finalists for the... ► Artikel lesen | |
| Mi | Humacyte, Inc: Humacyte Appoints Jim Mercadante as Chief Commercial Officer | GlobeNewswire (Europe) | - Industry veteran with more than 25 years of experience will lead next phase of biotech company's commercial expansion - - Seasoned medtech commercial leader brings extensive field-specific success... ► Artikel lesen | |
| Mi | Degroof Petercam Initiates Medincell's Coverage with a "Buy" Recommendation | Business Wire | Degroof Petercam, a leading European investment bank with strong healthcare expertise, has initiated coverage of Medincell In a report entitled "Royalty flywheel approaching profitability", the... ► Artikel lesen | |
| Mi | RedHill Biopharma Ltd.: RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026 | PR Newswire | New preclinical data, independently presented in two posters at the 2026 American Association for Cancer Research (AACR) Annual Meeting, show positive effects of... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MODERNA INC finden Sie auf Wallstreet Online.